PROMOMED opened a new division at the Russian Trade Representation in China on November 13, focusing on joint drug development, molecular research, and clinical trials.
Company chairman and co-owner Pyotr Bely told Sputnik that the initiative would support the exchange of pharmaceutical developments between Russia and China, bringing new treatments to doctors and patients in both countries.
china, russia, pharmaceuticals, research, patients, doctors, medicine
Access to the chat has been blocked for violating the rules . You will be able to participate again through:∞. If you do not agree with the blocking, please use the feedback form
The discussion is closed. You can participate in the discussion within 24 hours after the publication of the article.